| A Prospective Study of Inflammation-Based Markers for Lung Cancer Risk and Survival in African Americans |
Brid Ryan |
NCI |
PLCO |
Dec 21, 2018 |
2018-1020 |
| Genetic and environmental determinants of the oral microbiota |
Christian Abnet |
NCI/DCEG |
PLCO |
Dec 21, 2018 |
2018-1016 |
| A Prospective Investigation of Microbial Metabolites and Colorectal Cancer |
Erikka Loftfield |
National Cancer Instiute |
PLCO |
Dec 21, 2018 |
2018-1017 |
| Low dose aspirin use from SQX and risk of ovarian cancer |
Britton Trabert |
University of Utah/Huntsman Cancer Institute |
PLCO |
Dec 18, 2018 |
PLCO-431 |
| Updated data request: Ovarian cancer risk factors by histologic subtypes and development of an ovarian cancer risk prediction model in the Ovarian Cancer Cohort Consortium (OC3) |
Nicolas Wentzensen |
DCEG, NCI |
PLCO |
Dec 11, 2018 |
PLCO-429 |
| Quantifying risk of prostate cancer in men with inflammatory bowel disease. |
Shilajit Kundu |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 11, 2018 |
PLCO-428 |
| The association of dietary glycemic index and glycemic load on ovarian cancer incidence and survival in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort |
Jennifer Mongiovi |
University at Buffalo |
PLCO |
Dec 11, 2018 |
PLCO-427 |
| Diet, Metabolic Biomarkers and Lung Cancer Risk |
Martin Carl Tammemagi |
Brock University |
PLCO |
Nov 19, 2018 |
PLCO-418 |
| Public Policy Recommendations Towards Colorectal Screenings |
Robert Henderson |
George Mason University |
PLCO |
Nov 13, 2018 |
PLCO-422 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project |
Danxia Yu |
Vanderbilt University Medical Center |
PLCO |
Nov 2, 2018 |
PLCO-414 |
| Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Nov 2, 2018 |
PLCO-417 |
| Lung Cancer Risk Prediction Modelling -- Extensions to the PLCOm2012 model |
Martin Carl Tammemagi |
Brock University |
PLCO |
Oct 26, 2018 |
PLCO-416 |
| Clinical Cancer Data Analysis |
Canan Eren |
New Jersey Institute of Technology |
PLCO |
Oct 26, 2018 |
PLCO-410 |
| Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jiaqi Huang |
NIH |
PLCO |
Oct 23, 2018 |
2017-1017 |
| Physical activity, PSA levels, and screen-detected prostate cancers. |
Yelena Tarasenko |
Georgia Southern University |
PLCO |
Oct 23, 2018 |
PLCO-415 |
| The use of data from Food Frequency Questionnaire (FFQ) for network analysis on cancer survivorship and food intake |
Linghan Qian |
Tufts University |
PLCO |
Oct 15, 2018 |
PLCO-405 |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO |
Paramita Saha-Chaudhuri |
McGill University |
PLCO |
Oct 12, 2018 |
PLCO-408 |
| Impact of colorectal cancer sidedness on the outcomes of colorectal cancer patients diagnosed within PLCO study |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Oct 12, 2018 |
PLCO-407 |
| Diabetes and Cancer Initiative |
Marc Gunter |
International Agency for Research on Cancer |
PLCO |
Oct 11, 2018 |
PLCO-397 |
